Your next doctor could very well be a bot. And bots, or automated programs, are likely to play a key role in finding cures for some of the most difficult-to-treat diseases and conditions. Artificial intelligence is rapidly moving into health care, led by some of the biggest technology companies and emerging startups using it to diagnose and respond to a raft of conditions. While technology has always played a role in medical care, a wave of investment from Silicon Valley and a flood of data from connected devices appear to be spurring innovation. "I think a tipping point was when Apple released its Research Kit," said Forrester Research analyst Kate McCarthy, referring to a program letting Apple users enable data from their daily activities to be used in medical studies.

Amazon meanwhile offers medical advice through applications on its voice-activated artificial assistant Alexa. Insilico is working on drugs for amyotrophic lateral sclerosis (ALS), cancer and age-related diseases, aiming to develop personalised treatments.

Automated programs are likely to play a key role in finding cures for some of the most difficult-to-treat diseases. WASHINGTON: Your next doctor could very well be a bot. And bots, or automated programs, are likely to play a key role in finding cures for some of the most difficult-to-treat diseases and conditions. Artificial intelligence is rapidly moving into health care, led by some of the biggest technology companies and emerging startups using it to diagnose and respond to a raft of conditions. While technology has always played a role in medical care, a wave of investment from Silicon Valley and a flood of data from connected devices appear to be spurring innovation.

Amazon meanwhile offers medical advice through applications on its voice-activated artificial assistant Alexa. Insilico is working on drugs for amyotrophic lateral sclerosis (ALS), cancer and age-related diseases, aiming to develop personalised treatments.

Your next doctor could very well be a bot. And bots, or automated programs, are likely to play a key role in finding cures for some of the most difficult-to-treat diseases and conditions. Artificial intelligence is rapidly moving into health care, led by some of the biggest technology companies and emerging startups using it to diagnose and respond to a raft of conditions. While technology has always played a role in medical care, a wave of investment from Silicon Valley and a flood of data from connected devices appear to be spurring innovation. "I think a tipping point was when Apple released its Research Kit," said Forrester Research analyst Kate McCarthy, referring to a program letting Apple users enable data from their daily activities to be used in medical studies.

Your next doctor could very well be a bot. And bots, or automated programs, are likely to play a key role in finding cures for some of the most difficult-to-treat diseases and conditions. Artificial intelligence is rapidly moving into health care, led by some of the biggest technology companies and emerging startups using it to diagnose and respond to a raft of conditions. While technology has always played a role in medical care, a wave of investment from Silicon Valley and a flood of data from connected devices appear to be spurring innovation. "I think a tipping point was when Apple released its Research Kit," said Forrester Research analyst Kate McCarthy, referring to a program letting Apple users enable data from their daily activities to be used in medical studies.

Your next doctor could very well be a bot. And bots, or automated programs, are likely to play a key role in finding cures for some of the most difficult-to-treat diseases and conditions. Artificial intelligence is rapidly moving into health care, led by some of the biggest technology companies and emerging startups using it to diagnose and respond to a raft of conditions. While technology has always played a role in medical care, a wave of investment from Silicon Valley and a flood of data from connected devices appear to be spurring innovation. "I think a tipping point was when Apple released its Research Kit," said Forrester Research analyst Kate McCarthy, referring to a program letting Apple users enable data from their daily activities to be used in medical studies.